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Background
Atopic dermatitis (AD) is a chronic inflammatory derma-
tosis of the skin that leads to xerosis and pruritus. It is
known that the serum levels of total immunoglobulin E
(IgE) appear to be higher in patients with more severe
AD. Changes in skin barrier also demonstrate that there
is increased susceptibility to skin infections in AD,
including by viruses, such as herpes simplex virus (HSV).
Methods
The study was retrospective and cross-sectional, with
chart review. Patients were selected for monitoring in
the immunology service, aged between 16 and 75 years
with diagnosis of AD by Hanifin and Rajka criteria
updated in 2003, classified as mild, moderate or severe
AD by calculating the EASI (Eczema Area and Severity
Index), which had HSV serology and total IgE. Serology
was performed by ELISA (enzyme linked immunosorbent
assay) and serum total IgE by nephelometry with N
Latex IgE mono ®.
Results
Twenty-four patients participated in the study. Of these,
14 women, 13 white, 20 seropositive for HSV, six with
severeAD, 12 moderate and 6 severe. The total IgE
values were variable, with the highest observed in more
severe patients. Weana lyzed the clinical and laboratory
relationship between serum levels of total IgE and posi-
tive serology for HSV. This was not statist ically signifi-
cant relationship. Patients with highest total levels of
IgE were not more likely to express HSV infection, with
worst prognosis of AD.
Conclusions
There was no relationship between HSV soropositivity,
elevated IgE serum levels and increased severity of AD.
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